Addendum—PFE may have disclosed PF-06954522 without any fanfare because they didn’t want investors to infer that PFE has reduced confidence in Danuglipron.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”